- Zacks•2 days ago
Immunomedics, Inc. (IMMU) shares rose almost 7% in the last trading session.
- Business Wire•3 days ago
Fourth paragraph, second bullet of release should read: Fact: As Immunomedics’ largest stockholder, our interests are directly aligned with investors, which is why we are fighting for truly independent representation at the Board level, as evidenced by the fact that three of our four nominees are independent of venBio.
- GlobeNewswire•4 days ago
--Details Preclinical and Clinical Progress in Advancing IMMU-114, IMMU-130, IMMU-140, and Immuno-Oncology Program--. --Expresses Confidence in Near- and Long-Term Growth Prospects for Stockholders--. ...
IMMU : Summary for Immunomedics, Inc. - Yahoo Finance
Immunomedics, Inc. (IMMU)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.16 x 2000|
|Ask||4.27 x 5000|
|Day's Range||4.17 - 4.55|
|52 Week Range||1.61 - 5.44|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|